ea0092ps2-15-04 | Hyperthyroidism | ETA2023
Villagelin Danilo
, Perini Nicolas
, Santos Roberto
, Romaldini Joao
Introduction: GravesÂ’ disease is the leading cause of hyperthyroidism in the adult population. Antithyroid drugs (ATD) are the first choice worldwide, however, after an initial treatment course of 18-24 months, almost 40-50% will relapse. In these cases, current guidelines suggest a second course or prolonged use of ATD as an option. Recently, the study of quality of life (QOL) has obtained great importance, since the QOL in hyperthyroid patients is very affected. However...